Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...

In a report released today, Matthew Weston from UBS maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price target ...